{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:15:34Z","timestamp":1784895334883,"version":"3.55.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Mortality risk stratification may identify a subset of children who benefit from or are harmed by corticosteroid administration. The Pediatric Sepsis Biomarker Risk Model (PERSEVERE)-II score is a biomarker-based mortality risk stratification tool for pediatric sepsis. Our objective was to assess the association of corticosteroid administration with 28-day mortality within different levels of baseline mortality risk (PERSEVERE-II) in a cohort of children with septic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>We performed a secondary analysis using prospectively collected data (January 2015 to December 2018).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>PICUs in 13 tertiary care, academic centers in the United States.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Children with septic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>We assessed the association of corticosteroid administration within PERSEVERE-II risk score categories and 28-day mortality, ICU-free days, and maximum failed organs in children with septic shock. We analyzed a total of 461 patients (215 with corticosteroids exposure, 246 without corticosteroid exposure) with an average age of 7.1 years (interquartile range, 2.2\u201313.6 yr). In the subgroup of patients with a high PERSEVERE-II score, corticosteroid administration was associated with an increased adjusted risk of 28-day mortality (odds ratio [OR] 4.10 [95% CI 1.70\u20139.86]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.002), but not in the low risk group (OR 0.20 [95% CI 0.02\u20131.73]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.15). A significant interaction between PERSEVERE-II score and corticosteroids was seen for both secondary outcomes complicated course (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.01) and maximum failed organs (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001). Corticosteroid exposure was associated with fewer ICU-free days (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>In our multicenter observational study, corticosteroid administration was associated with increased mortality in a subgroup of children with a high PERSEVERE-II risk score.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003117","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T14:00:21Z","timestamp":1671804021000},"page":"186-193","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["The Association of Corticosteroids and Pediatric Sepsis Biomarker Risk Model (PERSEVERE)-II Biomarker Risk Stratification With Mortality in Pediatric Septic Shock*"],"prefix":"10.1097","volume":"24","author":[{"given":"Jennifer A.","family":"Klowak","sequence":"first","affiliation":[{"name":"Division of Pediatric Critical Care, Children\u2019s Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vid","family":"Bijeli\u0107","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Barrowman","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusum","family":"Menon","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care, Children\u2019s Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada."},{"name":"Children\u2019s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Genomics of Pediatric Septic Shock Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,23]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201412-2323OC","article-title":"Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study.","volume":"191","author":"Weiss","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/PCC.0b013e3181d903f6","article-title":"Adjunctive corticosteroid therapy in pediatric severe sepsis: Observations from the RESOLVE study.","volume":"12","author":"Zimmerman","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/PCC.0000000000000225","article-title":"Pediatric severe sepsis in U.S. children\u2019s hospitals.","volume":"15","author":"Balamuth","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1097\/PCC.0000000000002198","article-title":"Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/PEC.0000000000000561","article-title":"A survey of attitudes and practices regarding the use of steroid supplementation in pediatric sepsis.","volume":"31","author":"Carmean","year":"2015","journal-title":"Pediatr Emerg Care"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PCC.0b013e31828a7287","article-title":"A survey of stated physician practices and beliefs on the use of steroids in pediatric fluid and\/or vasoactive infusion-dependent shock.","volume":"14","author":"Menon","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/PCC.0b013e31828a8125","article-title":"A systematic review and meta-analysis on the effect of steroids in pediatric shock.","volume":"14","author":"Menon","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.PCC.0000160596.31238.72","article-title":"A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: What is the role of steroids?","volume":"6","author":"Markovitz","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/SHK.0000000000000355","article-title":"A cohort study of pediatric shock: Frequency of corticosteriod use and association with clinical outcomes.","volume":"44","author":"Menon","year":"2015","journal-title":"Shock"},{"key":"R10-20250502","first-page":"CD002243","article-title":"Corticosteroids for treating sepsis in children and adults.","volume":"12","author":"Annane","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201410-1864OC","article-title":"Developing a clinically feasible personalized medicine approach to pediatric septic shock.","volume":"191","author":"Wong","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/cc11652","article-title":"The pediatric sepsis biomarker risk model.","volume":"16","author":"Wong","year":"2012","journal-title":"Crit Care"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"e1127027","DOI":"10.1371\/journal.pone.0112702","article-title":"Corticosteroids and pediatric septic shock outcomes: A risk stratified analysis.","volume":"9","author":"Atkinson","year":"2014","journal-title":"PLoS One"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1097\/CCM.0000000000001852","article-title":"Pediatric sepsis biomarker risk model-II: Redefining the pediatric sepsis biomarker risk model with septic shock phenotype.","volume":"44","author":"Wong","year":"2016","journal-title":"Crit Care Med"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"eaax9000","DOI":"10.1126\/scitranslmed.aax9000","article-title":"Prospective clinical testing and experimental validation of the pediatric sepsis biomarker risk model.","volume":"11","author":"Wong","year":"2019","journal-title":"Sci Transl Med"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics.","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"e1000","DOI":"10.1097\/CCM.0000000000001833","article-title":"Combining prognostic and predictive enrichment strategies to identify children with septic shock responsive to corticosteroids.","volume":"44","author":"Wong","year":"2016","journal-title":"Crit Care Med"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"592303","DOI":"10.3389\/fimmu.2021.592303","article-title":"Machine learning identifies complicated sepsis course and subsequent mortality based on 20 genes in peripheral blood immune cells at 24 H Post-ICU admission.","volume":"12","author":"Banerjee","year":"2021","journal-title":"Front Immunol"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00003246-199605000-00004","article-title":"PRISM III: An updated pediatric risk of mortality score.","volume":"24","author":"Pollack","year":"1996","journal-title":"Crit Care Med"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2016.10.060","article-title":"Comparison of propensity score methods and covariate adjustment: Evaluation in 4 cardiovascular studies.","volume":"69","author":"Elze","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1007\/s12098-012-0706-z","article-title":"Epidemiology and outcome of sepsis in a tertiary care PICU of Pakistan.","volume":"79","author":"Khan","year":"2012","journal-title":"Indian J Pediatr"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1440-1754.1999.355409.x","article-title":"Sepsis, severe sepsis and septic shock in paediatric multiple organ dysfunction syndrome.","volume":"35","author":"Goh","year":"1999","journal-title":"J Paediatr Child Health"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0034-1398690","article-title":"Septic shock in children in an urban area in Western Germany--Outcome, risk factors for mortality and infection epidemiology.","volume":"227","author":"Breuling","year":"2015","journal-title":"Klin Padiatr"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.aller.2015.07.005","article-title":"Prognostic markers among Egyptian children with sepsis in the intensive care units, Cairo University Hospitals.","volume":"44","author":"Ibrahiem","year":"2016","journal-title":"Allergol Immunopathol (Madr)"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/CCM.0000000000005294","article-title":"Criteria for pediatric sepsis-A systematic review and meta-analysis by the pediatric sepsis definition taskforce.","volume":"50","author":"Menon","year":"2022","journal-title":"Crit Care Med"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1097\/CCM.0000000000002932","article-title":"Endotype transitions during the acute phase of pediatric septic shock reflect changing risk and treatment response.","volume":"46","author":"Wong","year":"2018","journal-title":"Crit Care Med"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:25:51Z","timestamp":1746206751000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003117","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,23]]}}}